REVB
NASDAQ · Biotechnology
Revelation Biosciences Inc
$1.05
-0.06 (-5.50%)
Open$1.14
Previous Close$1.11
Day High$1.14
Day Low$1.03
52W High$11.72
52W Low$0.88
Volume—
Avg Volume23.9K
Market Cap4.46M
P/E Ratio—
EPS$-17.64
SectorBiotechnology
Analyst Ratings
Strong Buy
7 analysts
Price Target
+873.3% upside
Current
$1.05
$1.05
Target
$10.21
$10.21
$7.91
$10.21 avg
$15.75
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 725.2K | 710.5K | 685.3K |
| Net Income | -167,658 | -204,058 | -214,742 |
| Profit Margin | -23.1% | -28.7% | -31.3% |
| EBITDA | -214,609 | -243,655 | -229,479 |
| Free Cash Flow | -113,026 | -111,014 | -146,791 |
| Rev Growth | -8.8% | +0.9% | +1.6% |
| Debt/Equity | 0.76 | 0.62 | 0.70 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $249.46 | -0.54% | 118.6 | 430.95B |
| AMGN | Amgen Inc | $415.21 | -0.63% | 25.1 | 219.39B |
| GILD | Gilead Sciences Inc | $138.36 | +0.16% | — | 165.85B |
| VRTX | Vertex Pharmaceuticals Inc | $505.75 | -2.07% | 28.3 | 124.51B |
| REGN | Regeneron Pharmaceuticals | $803.48 | -0.31% | 18.4 | 79.53B |
| ALNY | Alnylam Pharmaceuticals Inc | $228.65 | +0.67% | 35.2 | 28.41B |